Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CytomX Therapeutics (CTMX) Gains from Investment Securities (2016 - 2025)

CytomX Therapeutics' Gains from Investment Securities history spans 12 years, with the latest figure at $2.2 million for Q4 2025.

  • For Q4 2025, Gains from Investment Securities fell 84.98% year-over-year to $2.2 million; the TTM value through Dec 2025 reached $2.2 million, down 84.98%, while the annual FY2025 figure was $2.2 million, 84.98% down from the prior year.
  • Gains from Investment Securities reached $2.2 million in Q4 2025 per CTMX's latest filing, up from $413350.0 in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $16.8 million in Q1 2025 to a low of $413350.0 in Q3 2025.
  • Average Gains from Investment Securities over 5 years is $8.0 million, with a median of $9.1 million recorded in 2021.
  • Peak YoY movement for Gains from Investment Securities: plummeted 96.36% in 2022, then soared 1603.81% in 2024.
  • A 5-year view of Gains from Investment Securities shows it stood at $12.2 million in 2021, then grew by 9.0% to $13.3 million in 2022, then dropped by 2.56% to $12.9 million in 2023, then increased by 12.45% to $14.6 million in 2024, then tumbled by 84.98% to $2.2 million in 2025.
  • Per Business Quant, the three most recent readings for CTMX's Gains from Investment Securities are $2.2 million (Q4 2025), $413350.0 (Q3 2025), and $6.3 million (Q2 2025).